Summary
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
Featured Authors
Patricia Ryan, MD
The Ohio State University
Sonil Patil, MD, MPH
Case Western Reserve University
Hollie Goodell, RN
Ohio University
Marilee Clemons, PharmD, BCACP
University of Toledo